The University of Chicago Header Logo

Connection

Jasmin Tiro to Female

This is a "connection" page, showing publications Jasmin Tiro has written about Female.
Connection Strength

1.528
  1. Data gaps and opportunities for modeling cancer health equity. J Natl Cancer Inst Monogr. 2023 11 08; 2023(62):246-254.
    View in: PubMed
    Score: 0.046
  2. Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
    View in: PubMed
    Score: 0.044
  3. Population-based correlates of COVID-19 infection: An analysis from the DFW COVID-19 prevalence study. PLoS One. 2022; 17(12):e0278335.
    View in: PubMed
    Score: 0.043
  4. The impact of intimate partner violence on breast and cervical cancer survivors in an integrated, safety-net setting. J Cancer Surviv. 2020 12; 14(6):906-914.
    View in: PubMed
    Score: 0.037
  5. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.036
  6. Emergency Department Testing Patterns for Sexually Transmitted Diseases in North Texas. Sex Transm Dis. 2019 07; 46(7):434-439.
    View in: PubMed
    Score: 0.034
  7. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result. J Womens Health (Larchmt). 2019 03; 28(3):384-392.
    View in: PubMed
    Score: 0.033
  8. Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1398-1406.
    View in: PubMed
    Score: 0.032
  9. Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS. 2018 08 24; 32(13):1861-1870.
    View in: PubMed
    Score: 0.032
  10. Effects of program scale-up on time to resolution for patients with abnormal screening mammography results. Cancer Causes Control. 2018 Oct; 29(10):995-1005.
    View in: PubMed
    Score: 0.032
  11. Reducing "I Don't Know" Responses and Missing Survey Data: Implications for Measurement. Med Decis Making. 2018 08; 38(6):673-682.
    View in: PubMed
    Score: 0.032
  12. Parent-Provider Communication of HPV Vaccine Hesitancy. Pediatrics. 2018 06; 141(6).
    View in: PubMed
    Score: 0.032
  13. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655.
    View in: PubMed
    Score: 0.030
  14. County-level outcomes of a rural breast cancer screening outreach strategy: a decentralized hub-and-spoke model (BSPAN2). Transl Behav Med. 2017 06; 7(2):349-357.
    View in: PubMed
    Score: 0.030
  15. Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics. Patient Educ Couns. 2017 04; 100(4):736-741.
    View in: PubMed
    Score: 0.028
  16. Modification and validation of the Treatment Self Regulation Questionnaire to assess parental motivation for HPV vaccination of adolescents. Vaccine. 2016 09 22; 34(41):4985-4990.
    View in: PubMed
    Score: 0.028
  17. Characterizing safety-net providers' HPV vaccine recommendations to undecided parents: A pilot study. Patient Educ Couns. 2016 09; 99(9):1452-60.
    View in: PubMed
    Score: 0.028
  18. Validity of Single-Item Screening for Limited Health Literacy in English and Spanish Speakers. Am J Public Health. 2016 May; 106(5):889-92.
    View in: PubMed
    Score: 0.027
  19. Assessing race and ethnicity data quality across cancer registries and EMRs in two hospitals. J Am Med Inform Assoc. 2016 05; 23(3):627-34.
    View in: PubMed
    Score: 0.027
  20. Promoting HPV Vaccination in Safety-Net Clinics: A Randomized Trial. Pediatrics. 2015 Nov; 136(5):850-9.
    View in: PubMed
    Score: 0.026
  21. Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method. Breast Cancer Res Treat. 2015 Jun; 151(2):427-34.
    View in: PubMed
    Score: 0.026
  22. Competitive testing of health behavior theories: how do benefits, barriers, subjective norm, and intention influence mammography behavior? Ann Behav Med. 2014 Feb; 47(1):120-9.
    View in: PubMed
    Score: 0.023
  23. Does language moderate the influence of information scanning and seeking on HPV knowledge and vaccine awareness and initiation among Hispanics? Ethn Dis. 2013; 23(1):95-102.
    View in: PubMed
    Score: 0.022
  24. Understanding how mothers of adolescent girls obtain information about the human papillomavirus vaccine: associations between mothers' health beliefs, information seeking, and vaccination intentions in an ethnically diverse sample. J Health Psychol. 2013 Jul; 18(7):926-38.
    View in: PubMed
    Score: 0.021
  25. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila). 2012 Sep; 5(9):1124-30.
    View in: PubMed
    Score: 0.021
  26. Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. J Womens Health (Larchmt). 2012 Jun; 21(6):656-65.
    View in: PubMed
    Score: 0.021
  27. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med. 2012 Jul; 27(7):861-7.
    View in: PubMed
    Score: 0.020
  28. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012 Mar 16; 30(13):2368-75.
    View in: PubMed
    Score: 0.020
  29. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine. 2011 Jun 06; 29(25):4238-43.
    View in: PubMed
    Score: 0.019
  30. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer. 2008 Nov 15; 113(10 Suppl):3013-30.
    View in: PubMed
    Score: 0.016
  31. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):288-94.
    View in: PubMed
    Score: 0.014
  32. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2855-61.
    View in: PubMed
    Score: 0.013
  33. Validation of scales measuring attitudes and norms related to mammography screening in women veterans. Health Psychol. 2005 Nov; 24(6):555-66.
    View in: PubMed
    Score: 0.013
  34. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial. JAMA. 2023 11 28; 330(20):1971-1981.
    View in: PubMed
    Score: 0.012
  35. Disparities in Gynecologic Cancers. Cancer J. 2023 Nov-Dec 01; 29(6):343-353.
    View in: PubMed
    Score: 0.012
  36. Timing of Colposcopy and Risk of Cervical Cancer. Obstet Gynecol. 2023 11 01; 142(5):1125-1134.
    View in: PubMed
    Score: 0.011
  37. Characteristics of parents who think intrauterine devices or contraceptive implants are "best" for their daughter: An exploratory analysis in Dallas, Texas. Contraception. 2023 09; 125:110084.
    View in: PubMed
    Score: 0.011
  38. Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings. Am J Prev Med. 2023 10; 65(4):667-677.
    View in: PubMed
    Score: 0.011
  39. Parent Perspectives about Initiating Contraception Conversations with Adolescent Daughters. J Pediatr Adolesc Gynecol. 2023 Aug; 36(4):399-405.
    View in: PubMed
    Score: 0.011
  40. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
    View in: PubMed
    Score: 0.011
  41. Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care. Contraception. 2023 06; 122:109993.
    View in: PubMed
    Score: 0.011
  42. Provider beliefs in effectiveness and recommendations for primary HPV testing inĀ 3 health-care systems. JNCI Cancer Spectr. 2023 01 03; 7(1).
    View in: PubMed
    Score: 0.011
  43. Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 Nov 01; 5(11):e2244343.
    View in: PubMed
    Score: 0.011
  44. The Impact of Caregiver Depression on Child Asthma Outcomes: Pathways and Mechanisms. J Allergy Clin Immunol Pract. 2023 01; 11(1):200-209.
    View in: PubMed
    Score: 0.011
  45. Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
    View in: PubMed
    Score: 0.011
  46. Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial. Contemp Clin Trials. 2022 11; 122:106960.
    View in: PubMed
    Score: 0.011
  47. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 02; 12(3):3705-3717.
    View in: PubMed
    Score: 0.011
  48. Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics. Am J Prev Med. 2022 04; 62(4):538-547.
    View in: PubMed
    Score: 0.010
  49. Long-term Mammography Adherence among Uninsured Women Enrolled in the Breast Screening and Patient Navigation (BSPAN) Program. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):77-84.
    View in: PubMed
    Score: 0.010
  50. Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 01; 154:106871.
    View in: PubMed
    Score: 0.010
  51. De-implementation of cervical cancer screening before age 21. Prev Med. 2021 12; 153:106815.
    View in: PubMed
    Score: 0.010
  52. Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual. Med Care. 2021 05 01; 59(5):461-466.
    View in: PubMed
    Score: 0.010
  53. T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Front Immunol. 2021; 12:624230.
    View in: PubMed
    Score: 0.010
  54. Multivariate Association of Child Depression and Anxiety with Asthma Outcomes. J Allergy Clin Immunol Pract. 2021 06; 9(6):2399-2405.
    View in: PubMed
    Score: 0.010
  55. Anal cancer screening among women with HIV: provider experiences and system-level challenges. AIDS Care. 2022 02; 34(2):220-226.
    View in: PubMed
    Score: 0.010
  56. Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV. J Low Genit Tract Dis. 2021 Jan 01; 25(1):43-47.
    View in: PubMed
    Score: 0.009
  57. Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. Prev Med. 2021 04; 145:106410.
    View in: PubMed
    Score: 0.009
  58. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021 03 15; 127(6):850-864.
    View in: PubMed
    Score: 0.009
  59. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2020 08; 52(4):701-709.
    View in: PubMed
    Score: 0.009
  60. Authors' response: Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populations. Prev Med. 2020 10; 139:106081.
    View in: PubMed
    Score: 0.009
  61. Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma. PLoS One. 2020; 15(3):e0229569.
    View in: PubMed
    Score: 0.009
  62. Cost-effectiveness studies of HPV self-sampling: A systematic review. Prev Med. 2020 03; 132:105953.
    View in: PubMed
    Score: 0.009
  63. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits. J Med Screen. 2020 09; 27(3):146-156.
    View in: PubMed
    Score: 0.009
  64. Evaluating the Validity of the Risk Perception Survey for Developing Diabetes Scale in a Safety-Net Clinic Population of English and Spanish Speakers. Diabetes Educ. 2020 02; 46(1):73-82.
    View in: PubMed
    Score: 0.009
  65. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial. JAMA Netw Open. 2019 11 01; 2(11):e1914729.
    View in: PubMed
    Score: 0.009
  66. Understanding Underuse of Advance Care Planning Among a Cohort of African American Patients With Advanced Cancer: Formative Research That Examines Gaps in Intent to Discuss Options for Care. Am J Hosp Palliat Care. 2019 Dec; 36(12):1057-1062.
    View in: PubMed
    Score: 0.008
  67. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 03 15; 144(6):1460-1473.
    View in: PubMed
    Score: 0.008
  68. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial. Hepatology. 2019 01; 69(1):121-130.
    View in: PubMed
    Score: 0.008
  69. Social Disadvantage, Healthcare Utilization, and Colorectal Cancer Screening: Leveraging Longitudinal Patient Address and Health Records Data. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1424-1432.
    View in: PubMed
    Score: 0.008
  70. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 05; 113(5):746-754.
    View in: PubMed
    Score: 0.008
  71. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. Contemp Clin Trials. 2018 01; 64:77-87.
    View in: PubMed
    Score: 0.008
  72. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA. 2017 09 05; 318(9):806-815.
    View in: PubMed
    Score: 0.008
  73. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
    View in: PubMed
    Score: 0.007
  74. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study. Oncol Nurs Forum. 2017 05 01; 44(3):E101-E110.
    View in: PubMed
    Score: 0.007
  75. High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System. J Womens Health (Larchmt). 2017 06; 26(6):655-661.
    View in: PubMed
    Score: 0.007
  76. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatology. 2017 04; 65(4):1196-1205.
    View in: PubMed
    Score: 0.007
  77. Hispanic and Immigrant Paradoxes in U.S. Breast Cancer Mortality: Impact of Neighborhood Poverty and Hispanic Density. Int J Environ Res Public Health. 2016 12 14; 13(12).
    View in: PubMed
    Score: 0.007
  78. Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma. Gastroenterology. 2017 02; 152(3):608-615.e4.
    View in: PubMed
    Score: 0.007
  79. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis. Hepatology. 2017 03; 65(3):875-884.
    View in: PubMed
    Score: 0.007
  80. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med. 2017 Jan; 130(1):93.e1-93.e7.
    View in: PubMed
    Score: 0.007
  81. Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps. Cancer Epidemiol Biomarkers Prev. 2016 11; 25(11):1449-1455.
    View in: PubMed
    Score: 0.007
  82. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med. 2016 Apr; 31(4):372-9.
    View in: PubMed
    Score: 0.007
  83. The Desires of Their Hearts: The Multidisciplinary Perspectives of African Americans on End-of-Life Care in the African American Community. Am J Hosp Palliat Care. 2017 Jul; 34(6):510-517.
    View in: PubMed
    Score: 0.007
  84. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer. 2016 Feb 01; 122(3):456-63.
    View in: PubMed
    Score: 0.007
  85. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015 Jun; 107(6):djv120.
    View in: PubMed
    Score: 0.006
  86. Residential racial segregation and mortality among black, white, and Hispanic urban breast cancer patients in Texas, 1995 to 2009. Cancer. 2015 Jun 01; 121(11):1845-55.
    View in: PubMed
    Score: 0.006
  87. Role functioning is associated with survival in patients with hepatocellular carcinoma. Qual Life Res. 2015 Jul; 24(7):1669-75.
    View in: PubMed
    Score: 0.006
  88. Effectiveness of a community research registry to recruit minority and underserved adults for health research. Clin Transl Sci. 2015 Feb; 8(1):82-4.
    View in: PubMed
    Score: 0.006
  89. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med. 2015 Jan; 128(1):90.e1-7.
    View in: PubMed
    Score: 0.006
  90. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):791-8.e1.
    View in: PubMed
    Score: 0.006
  91. Impediments and facilitators to physical activity and perceptions of sedentary behavior among urban community residents: the Fair Park Study. Prev Chronic Dis. 2013 Oct 31; 10:E177.
    View in: PubMed
    Score: 0.006
  92. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1101-8.
    View in: PubMed
    Score: 0.006
  93. Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors. J Cancer Surviv. 2013 Dec; 7(4):624-9.
    View in: PubMed
    Score: 0.006
  94. Human papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation. Womens Health Issues. 2013 Mar-Apr; 23(2):e131-41.
    View in: PubMed
    Score: 0.006
  95. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol. 2013 Mar; 108(3):425-32.
    View in: PubMed
    Score: 0.005
  96. Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv. 2013 Mar; 7(1):155-63.
    View in: PubMed
    Score: 0.005
  97. Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. Am J Public Health. 2013 Feb; 103(2):270-2.
    View in: PubMed
    Score: 0.005
  98. Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California. Vaccine. 2012 Apr 19; 30(19):3003-8.
    View in: PubMed
    Score: 0.005
  99. Understanding impediments and enablers to physical activity among African American adults: a systematic review of qualitative studies. Health Educ Res. 2011 Dec; 26(6):1010-24.
    View in: PubMed
    Score: 0.005
  100. Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use? Cancer. 2011 Dec 15; 117(24):5450-60.
    View in: PubMed
    Score: 0.005
  101. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer. 2011 Dec 15; 117(24):5560-8.
    View in: PubMed
    Score: 0.005
  102. Community events as viable sites for recruiting minority volunteers who agree to be contacted for future research. Contemp Clin Trials. 2011 May; 32(3):369-71.
    View in: PubMed
    Score: 0.005
  103. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis. J Natl Cancer Inst. 2010 Jul 21; 102(14):1023-39.
    View in: PubMed
    Score: 0.005
  104. Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care. 2010 Mar; 48(3):249-59.
    View in: PubMed
    Score: 0.004
  105. Construct validity of a mammography processes of change scale and invariance by stage of change. J Health Psychol. 2010 Jan; 15(1):64-74.
    View in: PubMed
    Score: 0.004
  106. One in four California adolescent girls have had human papillomavirus vaccination. Policy Brief UCLA Cent Health Policy Res. 2009 Feb; (PB2009-3):1-6.
    View in: PubMed
    Score: 0.004
  107. Mediating factors in the relationship between income and mammography use in low-income insured women. J Womens Health (Larchmt). 2008 Oct; 17(8):1371-8.
    View in: PubMed
    Score: 0.004
  108. Does patient health and hysterectomy status influence cervical cancer screening in older women? J Gen Intern Med. 2008 Nov; 23(11):1822-8.
    View in: PubMed
    Score: 0.004
  109. Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2231-7.
    View in: PubMed
    Score: 0.004
  110. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter? Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):758-67.
    View in: PubMed
    Score: 0.004
  111. Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial. J Natl Cancer Inst. 2008 Mar 05; 100(5):333-46.
    View in: PubMed
    Score: 0.004
  112. Promoting regular mammography screening II. Results from a randomized controlled trial in US women veterans. J Natl Cancer Inst. 2008 Mar 05; 100(5):347-58.
    View in: PubMed
    Score: 0.004
  113. Reported drop in mammography : is this cause for concern? Cancer. 2007 Jun 15; 109(12):2405-9.
    View in: PubMed
    Score: 0.004
  114. Lessons learned from developing a tailored print intervention: a guide for practitioners and researchers new to tailoring. Health Promot Pract. 2008 Jul; 9(3):281-8.
    View in: PubMed
    Score: 0.003
  115. Test-retest reliability of self-reported mammography in women veterans. Prev Med. 2006 Apr; 42(4):320-6.
    View in: PubMed
    Score: 0.003
  116. Additive impact of childhood emotional, physical, and sexual abuse on suicide attempts among low-income African American women. Suicide Life Threat Behav. 2002; 32(2):131-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.